SynCardia to Honor Eight Leading Total Artificial Heart Hospitals during ISHLT

UltraSight Raises $13 million to Bring AI Guidance for Cardiac Ultrasound to Patient Point of Care

The Yozma Group Korea, Atain Specialty Insurance Company and the Weizmann Institute of Science participated in the round.

Jon Hopkins New Senior Vice President-Chief Development Officer of Legion Healthcare Partners

Over the past 23 years, Jon has held various positions at Varian Medical Systems including Director of Sales, Americas West & Latin America, Varian Proton Solutions and prior Director of Worldwide Sales, Varian Particle Therapy.

Sinan Batman Appointed CTO of TeraRecon

Batman brings rich industry experience to TeraRecon, including Chief Engineer at Carestream/Kodak Health Group, where he defined the vision for image-centric workflow information systems.

This year’s awards recognize leadership in the Destination Therapy clinical trial, pioneering use of the 50cc Total Artificial Heart, outstanding outcomes, implant milestones and best launch

During the 37th annual meeting of the International Society for Heart & Lung Transplantation (ISHLT)* being held April 5-8 in San Diego, SynCardia Systems, LLC will honor the following eight hospitals for their lifesaving use of the SynCardia temporary Total Artificial Heart (TAH-t):

  • Destination Therapy Leader
    Virginia Commonwealth University (VCU) Medical Center
    Richmond, VA
    VCU Medical Center is the leading investigational site in the FDA-approved Investigational Device Exemption clinical trial of the 70cc Total Artificial Heart for destination therapy.
  • Pioneer Award – U.S.
    Ann & Robert H. Lurie Children’s Hospital of Chicago
    Chicago, IL
    Jaheim Whigham, 11, became the smallest and youngest patient to receive the 50cc Total Artificial Heart in the U.S. when Lurie Children’s performed its first implant in December 2016.
  • Pioneer Award – International
    Royal Brompton & Harefield NHS Foundation Trust
    London, United Kingdom
    Thanks to extraordinary cooperation between these two institutions, the smallest patient to receive the 50cc Total Artificial Heart in Europe was successfully bridged to transplant.
  • Outstanding Outcomes – U.S.
    University of Michigan Frankel Cardiovascular Center
    Ann Arbor, MI
    Eighty percent of patients who received the SynCardia Total Artificial Heart at Frankel Cardiovascular Center were bridged to transplant or are currently at home on support.
  • Outstanding Outcomes – International
    Montreal Heart Institute
    Quebec, Canada
    Eighty percent of patients who received the SynCardia Total Artificial Heart at Montreal Heart Institute were bridged to transplant.
  • Best Launch Award
    Tampa General Hospital (TGH)
    Tampa, FL
    TGH completed certification to implant the Total Artificial Heart in only 82 days and performed three implants during its first year as a SynCardia Certified Center.
  • Milestone Award – 175+ implants
    Heart and Diabetes Center NRW
    Bad Oeynhausen, Germany
  • Milestone Award – 100+ implants
    VCU Medical Center
    Richmond, VA
  • Milestone Award – 25 implants
    University of Washington Medical Center
    Seattle, WA

Attending ISHLT? Visit SynCardia at Booth 216 in the Harbor Ballroom at the Manchester Grand Hyatt San Diego.

*Awards are not part of the official ISHLT program

CAUTION – In the United States, the use of the SynCardia 70cc TAH-t for destination therapy is investigational.

CAUTION – In the United States, the SynCardia 50cc TAH-t is an investigational device, limited by federal law to investigational use.



Subscribe to Medical Device News Magazine here.

Related Articles